Clinical Trials
15 trialsNCT04984343 2026-04-23
FORT
Weill Medical College of Cornell University
Phase 2 Terminated
NCT04298983 2025-03-19
RAD 1805
University of Alabama at Birmingham
Phase 2 Terminated
NCT00321698 2024-08-29
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
OHSU Knight Cancer Institute
Phase 1/2 Terminated
NCT03066154 2024-06-03
DOP
The Netherlands Cancer Institute
Phase 1 Terminated
NCT03649841 2023-10-26
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer
University of Washington
Phase 2 Terminated
NCT00651326 2023-08-04
DART
Canadian Cancer Trials Group
Phase 3 Terminated
NCT04457245 2023-01-17
PSMA-dRT
Jonsson Comprehensive Cancer Center
Phase 3 Terminated
NCT02745587 2022-12-28
PROPER
University Hospital, Ghent
Phase 3 Terminated
NCT02508636 2021-10-12
Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer
University of California, San Francisco
Phase 2 Terminated
NCT03763851 2020-03-12
Cannabis Oil and Radiation Therapy for the Management of Pain
Tetra Bio-Pharma
Phase 2 Terminated
NCT02911922 2019-04-29
Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
Weill Medical College of Cornell University
Phase NA Terminated
NCT00348816 2017-12-08
Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Terminated
NCT00581113 2015-06-11
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
Virginia Commonwealth University
Phase 3 Terminated
NCT00388804 2012-08-08
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00480623 2012-03-23
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence
Agennix
Phase 1 Terminated